On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
5.901 - 5.925 of 94.502
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Intel Call 60,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,68x
- Analysis
- Intel Call 70,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 1,71x
- Analysis
- Regeneron Pharmaceuticals Call 1.050,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,33x
- Analysis
- Intel Call 64,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,74x
- Analysis
- Accenture Call 290,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,35x
- Analysis
- Regeneron Pharmaceuticals Call 1.040,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,31x
- Analysis
- Regeneron Pharmaceuticals Call 1.050,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,39x
- Analysis
- Chevron Call 270,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 3,69x
- Analysis
- Intel Call 68,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,98x
- Analysis
- Regeneron Pharmaceuticals Call 1.020,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,77x
- Analysis
- Robinhood Call 78,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,68x
- Analysis
- Gilead Sciences Call 190,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,98x
- Analysis
- Cisco Call 95,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,36x
- Analysis
- Gilead Sciences Call 195,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 3,23x
- Analysis
- Regeneron Pharmaceuticals Call 980,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,68x
- Analysis
- Spotify Technology Call 640,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,05x
- Analysis
- Regeneron Pharmaceuticals Call 980,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,51x
- Analysis
- Robinhood Call 76,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 1,98x
- Analysis
- Intel Call 72,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 1,71x
- Analysis
- Intel Call 66,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,77x
- Analysis
- Illumina, Inc. Call 230,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,74x
- Analysis
- Regeneron Pharmaceuticals Call 980,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,10x
- Analysis
- Costco Call 1.120,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,79x
- Analysis
- Eli Lilly Call 1.620,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,56x
- Analysis
- NXP Semiconductors NV Call 290,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,12x
- Analysis